Key result
Cisplatin induces dose-dependent cardiorenal injury markers with up to ~2.8-fold higher cardiac Bax in rats.
Why the study?
Cisplatin is widely used in chemotherapy, but its dose-dependent effects on different tissues are not fully understood.
Does acute cisplatin administration induce dose-dependent biochemical, molecular, and histopathological cardiorenal toxicity in a male Wistar rat model?
Does acute cisplatin administration induce dose-dependent biochemical, molecular, and histopathological cardiorenal toxicity in a male Wistar rat model?
In an acute rat model, cisplatin exposure induced dose-dependent cardiorenal toxicity characterized primarily by oxidative stress, mitochondrial apoptotic signaling (Bax/Bcl-2), and histopathological injury within 3 days, with more pronounced damage at doses of 7.5 and 12 mg/kg.
Answers are grounded in this paper and cite their sources.
Highlights early cardiorenal injury in cisplatin-treated rats; hypothesis-generating for mechanisms but should not change clinical practice.
Background/Objectives: Cisplatin (CP) is a widely used chemotherapeutic agent; however, its dose-dependent effects on different tissues are not fully understood. This study aimed to investigate the early dose-related cardiorenal toxicity of CP at biochemical, molecular, and histopathological levels. Methods: Male Wistar albino rats were divided into four groups: Control, 5 mg/kg CP, 7.5 mg/kg CP, and 12 mg/kg CP. Cardiac and renal tissues were collected three days after administration. Oxidative stress and inflammatory parameters were analyzed using ELISA. Histopathological evaluation and semi-quantitative scoring were performed on tissue sections. Apoptosis-related proteins were assessed using Western blotting and immunohistochemistry. Results: In both renal and cardiac tissues, LPO, MDA, and SOD levels showed significant dose-dependent changes, whereas inflammatory parameters did not differ significantly among the groups. Although Bax and Bcl-2 proteins displayed significant dose-dependent variations in both tissues at the protein level, immunohistochemical analyses showed no notable differences in cardiac tissue. Conclusions: Acute cisplatin exposure produced dose-related biochemical, molecular, and histopathological alterations in both cardiac and renal tissues. Oxidative stress-related changes were more prominent than cytokine-mediated inflammatory responses during the acute experimental period. Within the conditions of this acute model, lower cisplatin doses were associated with less pronounced tissue alterations.
No takes yet. Share an insight, caveat, or question.
Abuşoğlu et al. (2026) studied Cisplatin-induced acute cardiorenal toxicity (experimental rat model) (n=38). Cisplatin vs. Single intraperitoneal dose of 1 mL 0.9% isotonic saline was evaluated on Early dose-dependent cardiorenal toxicity markers (serological Troponin T, CK-MB, urea, creatinine; tissue MDA, LPO, SOD; Bax/Bcl-2 protein expression; histopathology) (p=<0.001). Cisplatin induced significant dose-dependent increases in cardiorenal injury markers and cardiac Bax in rats at 3 days.
Synapse has enriched 10 related papers. Consider them for comparative context: